Discover
LTRN
Lantern Pharma Inc.
1.55
2 x 1.24
2 x 2.03
bid
ask
-
0.16
9.36%
2 @ 04:03 AM
1.57 +0.02 (1.29%)
| Ytd | -48.84% | |
| 1y | -61.92% |
1.55
day range
1.75
1.11
52 week range
4.70
| Open | 1.75 | Prev Close | 1.71 | Low | 1.55 | High | 1.75 | Mkt Cap | 19.82M |
| Vol | 190.53K | Avg Vol | 141.52K | EPS | -1.63 | P/E | N/A | Forward P/E | -1.50 |
| Beta | 1.57 | Short Ratio | 4.74 | Inst. Own | 24.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 2.44 | 200-d Avg | 2.85 | 1yr Est | 20.50 |
LTRN News
benzinga.com
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript
Lantern Pharma (NASDAQ:LTRN) reported second-quarter financial results on Friday. The transcript fro
businesswire.com
Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Dev
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-native biopharma c